KESIMPTA (ofatumumab)

• KESIMPTA (ofatumumab)

• Topics

• (Abst.) Real-world safety and effectiveness of ofatumumab in MS:...

  Started by agate on 06 Mar, 2026 19:18

  Views: 8, Replies: 0

• T lymphopenia in MS patients treated with ofatumumab

  Started by agate on 04 Jan, 2026 21:17

  Views: 12, Replies: 0

• (Abst.) 6-year safety and efficacy outcomes w/first-line ofatumumab in recently diagnosed pts. w/relapsing MS

  Started by agate on 12 Dec, 2025 21:13

  Views: 18, Replies: 0

• (Abst.) Association of body mass index and clinical response in MS patients receiving ofatumumab

  Started by agate on 07 Mar, 2025 07:00

  Views: 107, Replies: 0

• (Abst.) Ofatumumab-associated colitis: A case report

  Started by agate on 02 Feb, 2025 07:24

  Views: 82, Replies: 0

• (Abst.) IV ofatumumab treatment of MS and related disorders...

  Started by agate on 25 Oct, 2022 21:20

  Views: 207, Replies: 0

• (Abst.) Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive MS patients

  Started by agate on 25 Jul, 2022 21:25

  Views: 161, Replies: 0

• Ofatumumab

  Started by agate on 25 Jan, 2014 19:47
  Last post by agate on 21 Aug, 2020 07:48

  Views: 902, Replies: 8